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Background
Few T-cell immunogen vaccine designs exist that are
based on large human immunogenicity data and which
avoid inducing responses to mutable epitopes that may
serve as immunodominant decoys. We have developed
and tested a rationally designed T cell immunogen
sequence which overcomes these limitations and which
is currently undergoing pre-clinical testing.
Methods
250 HIV-1 clade B infected individuals were screened
for T cell responses to the entire HIV proteome. This
yielded 26 regions in HIV-1 Gag, Pol, Vif and Nef pro-
teins that were i) preferentially targeted by individuals
with low viral loads, ii) more conserved and iii) elicited
responses of higher functional avidity and broader
cross-reactivity than responses to other, less-beneficial
regions. The ‘beneficial’ segments were linked by triple
alanines, translated into an expression-optimized
nucleotide sequence and cloned into a CMV plasmid
harboring a GM-CSF signal peptide. Immunogenicity
was evaluated in C57BL/6 mice two weeks after a sec-
ond DNA vaccination. Cellular immune responses were
characterized using intracellular cytokine staining and
IFN-g ELISPOT using overlapping peptide pools cover-
ing the segments included in the T-cell immunogen.
Results
Vaccination with 20 μg of DNA generated both CD4 and
CD8 IFN-g+ responses to the immunogen sequence. The
T-cell immunogen elicited a more balanced, broad T cell
response to all protein components (Gag, Pol, Vif and
Nef) contained in the immunogen than immunizations
using plasmids encoding for the entire Gag, Pol, Nef, Tat
and Vif proteins, which induced a strong Gag dominance.
Conclusion
Despite lower in vitro expression, the DNA vaccine was
strongly immunogenic in C57BL/6 mice, induced broad
CD4 and CD8 T cell responses and was able to break
the immunodominance of responses to targets that do
not emerge as particularly beneficial in large cohort
screenings. Experiments in humanized BLT mice are
currently ongoing to map induced responses in the con-
text of different HLA genotypes.
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